Separation of the principal HDL subclasses by iodixanol ultracentrifugation

Journal of Lipid Research

Volumn 54, Issue 8, 2013, Pages 2273-2281

  Harman, Nicola L ^a   Griffin, Bruce A ^b   Davies, Ian G ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Atherogenic lipoprotein phenotype; Cardiovascular disease; HDL 2; HDL 3; HDL subfractions; High density lipoprotein; LDL subclasses; Plasma lipoproteins; Plasma triacylglycerol; Self generating gradients

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IODIXANOL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FEMALE; FRACTIONATION; GEL ELECTROPHORESIS; GRADIENT GEL ELECTROPHORESIS; HUMAN; IMAGING SOFTWARE; LIPID ANALYSIS; MALE; NORMAL HUMAN; PHENOTYPE; PHOTOGRAPHY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

EID: 84881219732     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D037432     Document Type: Article

References (38)

1. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber.1977.High-density lipoprotein as a protective factor against coronary heart-disease. The Framingham Study. Am. J. Med. 62 : 707-714.
2. Castelli, W. P., R. J. Garrison, P. W. Wilson, R. D. Abbott, S. Kalousdian, and W. B. Kannel.1986.Incidence of coronary heartdisease and lipoprotein cholesterol levels. The Framingham-Study. JAMA.256 : 2835-2838.
3. Brown, B. G., X. Q. Zhao, A. Chait, L. D. Fisher, M. C. Cheung, J. S. Morse, A. A. Dowdy, E. K. Marino, E. L. Bolson, P. Alaupovic, et al. 2001.Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med. 345 : 1583-1592.
4. Frick, M. H., O. Elo, K. Haapa, O. P. Heinonen, P. Heinsalmi, P. Helo, J. K. Huttunen, P. Kaitaniemi, P. Koskinen, V. Manninen, et al. 1987.Helsinki Heart-Study: Primary-prevention trial with gemfi-brozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk-factors, and incidence of coronary heart disease. N. Engl. J. Med. 317 : 1237-1245.
5. Barter, P. J., M. Caulfield, M. Eriksson, S. M. Grundy, J. J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J. C. Tardif, D. D. Waters, et al.2007.Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357 : 2109-2122.
6. Otocka-Kmiecik, A., D. P. Mikhailidis, S. J. Nicholls, M. Davidson, J. Rysz, and M. Banach.2012.Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease? Prog. Lipid Res. 51 : 314-324.
7. Drexel, H., F. W. Amann, K. Rentsch, C. Neuenschwander, A. Luethy, S. I. Khan, and F. Follath.1992.Relation of the level of high-density-lipoprotein subfractions to the presence and extent of coronary-artery disease. Am. J. Cardiol. 70 : 436-440.
8. Asztalos, B. F., D. Collins, L. A. Cupples, S. Demissie, K. V. Horvath, H. E. Bloomfield, S. J. Robins, and E. J. Schaefer.2005.Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler. Thromb. Vasc. Biol. 25 : 2185-2191.
9. Salonen, J. T., R. Salonen, K. Seppänen, R. Rauramaa, and J. Tuomilehto. 1991.HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial-infarction. A prospective population study in eastern Finnish men. Circulation.84 : 129-139.
10. Williams, P. T., W. L. Haskell, K. M. Vranizan, and R. M. Krauss.1995. The associations of high-density-lipoprotein subclasses with insulinlevels and glucose-levels, physical-activity, resting heart-rate, and regional adiposity in men with coronary-artery-disease: The Stanford Coronary Risk Intervention Project baseline survey. Metabolism.44 : 106-114.
11. Superko, H. R., L. Pendyala, P. T. Williams, K. M. Momary, S. B. King 3rd, and B. C. Garrett.2012.High-density lipoprotein subclasses and their relationship to cardiovascular disease. J. Clin. Lipidol. 6 : 496-523.
12. Buring, J. E., G. T. O'Connor, S. Z. Goldhaber, B. Rosner, P. N. Herbert, C. B. Blum, J. L. Breslow, and C. H. Hennekens.1992. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation.85 : 22-29.
13. Sweetnam, P. M., C. H. Bolton, J. W. Yarnell, D. Bainton, I. A. Baker, P. C. Elwood, and N. E. Miller.1994.Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation.90 : 769-774.
14. Yu, S., J. W. Yarnell, P. Sweetnam, and C. H. Bolton.2003.High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study. Atherosclerosis.166 : 331-338.
15. Chung, M., A. H. Lichtenstein, S. Ip, J. Lau, and E. M. Balk. 2009. Comparability of methods for LDL subfraction determination: A systematic review. Atherosclerosis.205 : 342-348.
16. Kontush, A., S. Chantepie, and M. J. Chapman.2003.Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23 : 1881-1888.
17. Groot, P. H., L. M. Scheek, L. Havekes, W. L. van Noort, and F. M. van't Hooft.1982.A one-step separation of human serum high density lipoproteins 2 and 3 by rate-zonal density gradient ultracentrifugation in a swinging bucket rotor. J. Lipid Res. 23 : 1342-1353.
18. Chung, B. H., J. P. Segrest, J. T. Cone, J. Pfau, J. C. Geer, and L. A. Duncan.1981.High resolution plasma lipoprotein cholesterol profiles by a rapid, high volume semi-automated method. J. Lipid Res. 22 : 1003-1014.
19. Graham, J. M., J. A. Higgins, T. Gillott, T. Taylor, J. Wilkinson, T. Ford, and D. Billington.1996.A novel method for the rapid separation of plasma lipoproteins using self-generating gradients of iodixanol. Atherosclerosis.124 : 125-135.
20. Ford, T., J. Graham, and D. Rickwood.1994.Iodixanol: A nonionic iso-osmotic centrifugation medium for the formation of self-generated gradients. Anal. Biochem. 220 : 360-366.
21. Murdoch, S. J., and W. C. Breckenridge.1994.Development of a density gradient ultracentrifugation technique for the resolution of plasma lipoproteins which avoids apo E dissociation. Anal. Biochem. 222 : 427-434.
22. Davies, I. G., J. M. Graham, and B. A. Griffin.2003.Rapid separation of LDL subclasses by iodixanol gradient ultracentrifugation. Clin. Chem. 49 : 1865-1872.
23. Swinkels, D. W., H. L. M. Haklemmers, and P. N. M. Demacker. 1987.Single spin-density gradient ultracentrifugation method for the detection and isolation of light and heavy low-density-lipoprotein subfractions. J. Lipid Res. 28 : 1233-1239.
24. Terpstra, A. H. M., C. J. H. Woodward, and F. J. Sanchez-Muniz. 1981.Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: Visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum. Anal. Biochem. 111 : 149-157.
25. Kulkarni, K. R., S. M. Marcovina, R. M. Krauss, D. W. Garber, A. M. Glasscock, and J. P. Segrest.1997.Quantification of HDL2 and HDL3 cholesterol by the Vertical Auto Profile-II (VAP-II) methodology. J. Lipid Res. 38 : 2353-2364.
26. Otvos, J. D., E. J. Jeyarajah, D. W. Bennett, and R. M. Krauss.1992. Development of a proton nuclear-magnetic-resonance spectroscopic method for determining plasma-lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin. Chem. 38 : 1632-1638.
27. Ala-Korpela, M., A. Korhonen, J. Keisala, S. Hörkkö, P. Korpi, L. P. Ingman, J. Jokisaari, M. J. Savolainen, and Y. A. Kesäniemi. 1994.1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. J. Lipid Res. 35 : 2292-2304.
28. Sawle, A., M. K. Higgins, M. P. Olivant, and J. A. Higgins.2002. A rapid single-step centrifugation method for determination of HDL, LDL, and VLDL cholesterol, and TG, and identification of predominant LDL subclass. J. Lipid Res. 43 : 335-343.
29. Yee, M. S., D. V. Pavitt, T. Tan, S. Venkatesan, I. F. Godsland, W. Richmond, and D. G. Johnston.2008.Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis. J. Lipid Res. 49 : 1364-1371.
30. Griffin, B. A., M. J. Caslake, B. Yip, G. W. Tait, C. J. Packard, and J. Shepherd.1990.Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis.83 : 59-67.
31. Griffin, B. A., D. J. Freeman, G. W. Tait, J. Thomson, M. J. Caslake, C. J. Packard, and J. Shepherd.1994.Role of plasma triglyceride in the regulation of plasma low-density-lipoprotein (LDL) subfractions: Relative contribution of small, dense ldl to coronary heartdisease risk. Atherosclerosis.106 : 241-253.
32. Austin, M. A., J. L. Breslow, C. H. Hennekens, J. E. Buring, W. C. Willet, and R. M. Krauss.1988.Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA.260 : 1917-1921.
33. Rosenson, R. S., H. B. Brewer, Jr., M. J. Chapman, S. Fazio, M. M. Hussain, A. Kontush, R. M. Krauss, J. D. Otvos, A. T. Remaley, and E. J. Schaefer.2011.HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin. Chem. 57 : 392-410.
34. Syvänne, M., M. Ahola, S. Lahdenperä, J. Kahri, T. Kuusi, K. S. Virtanen, and M. R. Taskinen.1995.High density-lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J. Lipid Res. 36 : 573-582.
35. Xu, Y., and M. Fu.2003.Alterations of HDL subclasses in hyperlipidemia. Clin. Chim. Acta.332 : 95-102.
36. Yang, Y., B. Yan, M. Fu, Y. Xu, and Y. Tian.2005.Relationship between plasma lipid concentrations and HDL subclasses. Clin. Chim. Acta.354 : 49-58.
37. Griffin, B. A., A. M. Minihane, N. Furlonger, C. Chapman, M. Murphy, D. Williams, J. J. Wright, and C. M. Williams.1999.Interrelationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Clin. Sci. (Lond.).97 : 269-276.
38. Austin, M. A., M. C. King, K. M. Vranizan, and R. M. Krauss.1990. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation.82 : 495-506.